GlobalData hands you the landscape as an export, and you sort it in Excel, program by program. Sleuth includes the same database, scores every program on your criteria, and keeps the near misses in view.
Every Sleuth plan comes with the drugs, trials, companies, and deals you’d look up in GlobalData. Sleuth then builds the analysis for your question from them.
Landscapes, asset screens, and partner searches, narrowed on your own criteria, with a source on every value.
Your team needs country pricing and HTA every week.
A database subscription
$20K+ a year
The database alone. The analysis is still on you.
Sleuth
From $249 a month
Everything your database has, plus 3,000 credits a month.
Sleuth
GlobalData
Sleuth
Included in every plan: drugs, trials, companies, and deals in one knowledge base. Browsing is free and doesn’t use credits.
GlobalData
Drugs, trials, companies, and deals, sold as a subscription. Sorting them for your question is up to you.
Sleuth
The standard fields, plus any column you ask for. Ask “who holds the rights outside the US?” and Sleuth adds it as a column, filled in for every program.
GlobalData
The same fields for every subscriber. A question that cuts across them, like which companies raised money on a Parkinson’s lead asset, gets pieced together by hand.
Sleuth
Click any value to see the filing, registry entry, or broker note behind it, with its date, a confidence score, and whether it’s sourced, inferred, or unknown. Sleuth flags the few cells worth checking.
GlobalData
You check the records yourself. Its AI assistant answers “from within your subscription.”
Sleuth
Sleuth scores every program on your criteria, gives the reason for each score, and keeps the programs that just missed in view.
GlobalData
You filter, export, and go through the list in Excel, program by program.
Sleuth
Turn on monitoring, and the dataset updates as trials, filings, and deals come in, with a change log and every earlier version.
GlobalData
An export is fixed the day you pull it. To update it, you run the search again and redo the spreadsheet.
Sleuth
Sell-side research from 35+ providers, in every plan. You don’t need an account with each bank.
GlobalData
GlobalData’s own analyst reports, not sell-side research.
Sleuth
Epidemiology forecasts from SEER, CDC WONDER, NHANES, Eurostat, China CDC, and more. Prices go into an analysis when you ask, each with a source.
GlobalData
Maintained datasets: epidemiology forecasts, plus drug prices and HTA decisions by country.
GlobalData’s own pharma page says finding answers “shouldn’t feel like finding a needle in a haystack.” In Sleuth, each criterion is a column, filled in for every program and scored, with the near misses kept in view.
“Which Phase III MASH programs include F4 patients and are positioned to add on to a GLP-1?”
Explore the MASH landscapeA GlobalData export is fixed the day you pull it. Turn on monitoring, and Sleuth updates the same dataset as trials, deals, and filings come in, keeps every earlier version, and emails you what matters.
Sleuth’s analysts build these with the same tools you’d use in Sleuth, starting from every program in the knowledge base.
Most MASH drugs are still early, and only nine industry molecules are in Phase III.
How crowded each approach is, what tends to break these programs, and what deals and analysts imply about value.
Seven of nine targets have reached Phase 3 or approval, so outcomes data now separates programs.
Keep GlobalData if your team needs country pricing and HTA every week. For landscapes, asset screens, and partner searches, move to Sleuth.
List and reimbursed prices, country by country, tracked as they change.
What a course of treatment costs in each country, kept up as a dataset.
Health technology assessment outcomes by country, as each agency publishes them.
For landscapes, asset screens, partner searches, and deal work, yes. Every plan comes with the drugs, trials, companies, and deals you’d look up in GlobalData, and Sleuth narrows them on your criteria. Keep GlobalData if your team needs country pricing and HTA every week.
Yes. Every plan comes with 150K+ drugs, 1M+ trials from 20 registries, 400K+ companies, and 200K+ deals, at no extra cost. Browsing is free; Sleuth uses credits only for the analysis it builds on top.
Yes. Upload the Excel or CSV file, and Sleuth uses it as the starting dataset. Sleuth can add the columns your question needs, or find sources for the values already in the file without changing them.
Yes. Its AI assistant answers from GlobalData’s own databases and reports, within your subscription. Sleuth builds the analysis for your question from its knowledge base and the source documents, with a source, a date, and a confidence score on every value, in Studio or in Claude, ChatGPT, and Copilot.
Yes. Sleuth’s epidemiology data, from SEER, CDC WONDER, NHANES, Eurostat, China CDC, and more, sizes patient numbers and feeds its forecasts. Prices go into an analysis when you ask, each with its source and a confidence score. Keep GlobalData if your team needs country pricing and HTA decisions every week.
Starter is $249 a month for one person, and Team plans start at $499 a month for any number of people. Every plan includes the knowledge base, document search, and sell-side research. Try it free for 14 days, with no card.